VistaGen Therapeutics Inc (VTGN) Net Assets per Single Share
Vistagen Therapeutics (VTGN) is implementing AI modules and robotic screening for test analysis. The book value per share reflects the net asset trend, with the indicator currently standing at 0.55. Bioinformatics automation accelerates drug discovery by minimizing manual labor. Since demand for neuropsychiatric drugs remains stable regardless of GDP, business success depends on the results of clinical trials.
Summary analytical data breakdowns for VistaGen Therapeutics, Inc. (VTGN)
- stock price and consensus target price:
- market capitalization details:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Vistagen Therapeutics|VTGN - Long-Term Debt to Capital|Short-Term Debt to Equity VistaGen Therapeutics Inc|VTGN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Vistagen Therapeutics|VTGN - Long-Term Debt|Company Current Liabilities Vistagen|Quick Ratio vistagen.com
- earnings and multiples data:
General company analysis:VTGN - vistagen.com
Vistagen Therapeutics stability is based on the capitalization of intellectual assets created in partnership with psychiatric centers to develop neuroactive agents. The current book value per share of 0.55 reflects the remaining net assets after deducting all liabilities, allowing the investor to assess the intrinsic value of the business and compare actual capital with the market price of the security.
Main competitors
Biogen Corp - Book Value per Share|Book Value of One Share Neurocrine Corp (NBIX)|Regencell Bioscience (RGC) - Net Assets per Single Share|Equity per Share AXSM|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|Accounting Value per Share PRAX|Net Assets per Single Share AVXL|Book Value per Share CBLL|Net Assets per Share Prothena Corporation|Net Assets per Single Share Alector ALEC|Net Assets per Share Annexon Biosciences Inc. (ANNX)|OMER: Accounting Value per Share|neurogene.com - Book Price of a Share|ACIU: Book Value per Share|Voyager Therapeutics Inc (VYGR) - Book Value per Share|NMRA (Neumora Therapeutics Inc) - Book Value per Share|SCLX - Book Value of One Share|Book Value per Share TVGN|ACOG - Net Asset Value per Share|Net Assets per Single Share Cognition Therapeutics CGTX|IKT: Equity per Share|SAVA: Accounting Value per Share|Accounting Value of a Share ASRT (Assertio Holdings, Inc.)|COYA (coyatherapeutics.com) - Accounting Value per Share|OVID: Book Price of a Share|ABOS (Acumen Pharmaceuticals, Inc.) - Book Value per Share|CRVO: Accounting Value of a Share|Book Value per Share ATHE|CLNN - Net Asset Value per Share|Net Assets per Single Share PepGen PEPG|Accounting Value of a Share JUNS|Relmada Therapeutics, Inc. - Book Value per Share|ANVS - Book Value per Share|gracetx.com (GRCE) - Net Assets per Single Share|Share Book Value AIFF (Firefly Neuro)|KLTO (ANEW Medical) - Book Value per Share|Net Asset Value per Share NeuroSense Therapeutics, Ltd. NRSN|Accounting Value per Share RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Book Value per Share metaviatx.com (MTVA)|NeurAxis, Inc - Accounting Value per Share|Book Price of a Share HSDT (Helius Medical Technologies, Inc.)|Passage Bio Corp - Book Value per Share|Net Assets per Share Neuphoria Therapeutics Inc. NEUP|NERV: Book Value per Share|Accounting Value per Share Athira Pharma Inc|Net Assets per Single Share Addex Therapeutics, Ltd.|Alzamend (ALZN) - Net Assets per Share|Accounting Value per Share CYCN (Cyclerion Therapeutics)|Net Assets per Single Share PTIX (protagenic.com)|Pasithea Therapeutics Corp. - Accounting Value per Share|Book Price of a Share CRGT (Cortigent Inc)|Avenue Therapeutics, Inc - Book Value per Share|Book Value of One Share BrainStorm Cell Therapeutics Inc. (BCLI)|Cara Therapeutics, Inc. (CARA) - Net Assets per Single Share|Equity per Share CHRO|Net Assets per Single Share Eliem Therapeutics, Inc.|Equity per Share ITCI (Intra-Cellular)|Book Value per Share LBPH|MRNS - Net Asset Value per Share|NKGen Biotech, Inc. - Accounting Value per Share|Book Value per Share neurobopharma.com NRBO|SAGE - Net Assets per Single Share|Accounting Value of a Share SNPX (Synaptogenix Inc.)|Trevena, Inc (TRVN) - Net Assets per Single Share|Net Asset Value per Share Vigil Neuroscience, Inc. (VIGL)|Accounting Value per Share WENA|Net Assets per Single Share CERE